The action of antidepressants on the glutamate system: Regulation of glutamate release and glutamate receptors

Biological Psychiatry

Volumn 73, Issue 12, 2013, Pages 1180-1188

  Musazzi, Laura ^a   Treccani, Giulia ^a   Mallei, Alessandra ^a   Popoli, Maurizio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Antidepressant; drug development; glutamate neurotransmission; glutamate receptor; glutamate release; ketamine

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; AGOMELATINE; CITALOPRAM; DESIPRAMINE; DIAZEPAM; DULOXETINE; FLUOXETINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IMIPRAMINE; KETAMINE; MAPROTILINE; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PAROXETINE; REBOXETINE; SNARE PROTEIN; TIANEPTINE; VENLAFAXINE;

ANTIDEPRESSANT ACTIVITY; BRAIN NERVE CELL; BRAIN SIZE; CENTRAL NUCLEUS (AMYGDALA); CEREBROSPINAL FLUID ANALYSIS; DENTATE GYRUS; DEPRESSION; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; ENVIRONMENTAL FACTOR; EXCITATORY POSTSYNAPTIC POTENTIAL; EXERCISE; FUNCTIONAL NEUROIMAGING; HIPPOCAMPUS; HUMAN; MONOAMINERGIC SYSTEM; NERVOUS SYSTEM DEVELOPMENT; NEUROMODULATION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; REVIEW; STRUCTURE ACTIVITY RELATION; SYNAPTIC TRANSMISSION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DRUG DESIGN; GLUTAMIC ACID; HUMANS; RECEPTORS, GLUTAMATE;

EID: 84878408522     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.11.009     Document Type: Review

References (106)

1. F. Fonnum Glutamate: A neurotransmitter in mammalian brain J Neurochem 42 1984 1 11
2. R.J. Douglas, and K.A. Martin Mapping the matrix: The ways of neocortex Neuron 56 2007 226 238
3. M. Popoli, Z. Yan, B.S. McEwen, and G. Sanacora The stressed synapse: The impact of stress and glucocorticoids on glutamate transmission Nat Rev Neurosci 13 2012 22 37
4. J.H. Krystal, G. Sanacora, H. Blumberg, A. Anand, D.S. Charney, and G. Marek Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments Mol Psychiatry 7 2002 S71 S80
5. B.S. McEwen Glucocorticoids, depression, and mood disorders: Structural remodeling in the brain Metabolism 54 2005 20 23
6. G. Sanacora, G. Treccani, and M. Popoli Towards a glutamate hypothesis of depression: An emerging frontier of neuropsychopharmacology for mood disorders Neuropharmacology 62 2012 63 77
7. J.M. Gorman, and J.P. Docherty A hypothesized role for dendritic remodeling in the etiology of mood and anxiety disorders J Neuropsychiatry Clin Neurosci 22 2010 256 264
8. K. Tokita, T. Yamaji, and K. Hashimoto Roles of glutamate signaling in preclinical and/or mechanistic models of depression Pharmacol Biochem Behav 100 2012 688 704
9. M.C. Mauri, A. Ferrara, L. Boscati, S. Bravin, F. Zamberlan, M. Alecci, and G. Invernizzi Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment Neuropsychobiology 37 1998 124 129
10. H. Mitani, Y. Shirayama, T. Yamada, K. Maeda, C.R. Ashby Jr, and R. Kawahara Correlation between plasma levels of glutamate, alanine and serine with severity of depression Prog Neuropsychopharmacol Biol Psychiatry 30 2006 1155 1158
11. E. Küçükibrahimoǧlu, M.Z. Saygin, M. Calişkan, O.K. Kaplan, C. Unsal, and M.Z. Gören The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression Eur J Clin Pharmacol 65 2009 571 577
12. J. Levine, K. Panchalingam, A. Rapoport, S. Gershon, R.J. McClure, and J.W. Pettegrew Increased cerebrospinal fluid glutamine levels in depressed patients Biol Psychiatry 47 2000 586 593
13. M.A. Frye, G.E. Tsai, T. Huggins, J.T. Coyle, and R.M. Post Low cerebrospinal glutamate release: Effects of antidepressant drugs Neurochem Int 59 2007 138 149
14. P.T. Francis, A. Poynton, S.L. Lowe, A. Najlerahim, P.K. Bridges, and J.R. Bartlett Brain amino acid concentrations and Ca2+-dependent release in intractable depression assessed antemortem Brain Res 494 1989 315 324
15. K. Hashimoto, A. Sawa, and M. Iyo Increased levels of glutamate in brains from patients with mood disorders Biol Psychiatry 62 2007 1310 1316
16. M.J. Lan, G.A. McLoughlin, J.L. Grifn, T.M. Tsang, J.T. Huang, and P. Yuan Metabonomic analysis identies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder Mol Psychiatry 14 2009 269 279
17. C. Yüksel, and D. Öngür Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders Biol Psychiatry 68 2010 785 794
18. D.G. Kondo, T.L. Hellem, Y.H. Sung, N. Kim, E.K. Jeong, and K.K. Delmastro Review: Magnetic resonance spectroscopy studies of pediatric major depressive disorder Depress Res Treat 2011 2011 650450
19. G. Hasler, J.W. van der Veen, T. Tumonis, N. Meyers, J. Shen, and W.C. Drevets Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy Arch Gen Psychiatry 64 2007 193 200
20. M.J. Taylor, Z.N. Mannie, R. Norbury, J. Near, and P.J. Cowen Elevated cortical glutamate in young people at increased familial risk of depression Int J Neuropsychopharmacol 14 2010 255 259
21. P.C. Koolschijn, N.E. van Haren, G.J. Lensvelt-Mulders, H.E. Hulshoff Pol, and R.S. Kahn Brain volume abnormalities in major depressive disorder: A meta-analysis of magnetic resonance imaging studies Hum Brain Mapp 30 2009 3719 3735
22. V. Lorenzetti, N.B. Allen, A. Fornito, and M. Yücel Structural brain abnormalities in major depressive disorder: A selective review of recent MRI studies J Affect Disord 117 2009 1 17
23. T. Frodl, A. Schaub, S. Banac, M. Charypar, M. Jäger, and P. Kümmler Reduced hippocampal volume correlates with executive dysfunctioning in major depression J Psychiatry Neurosci 31 2006 316 323
24. G.M. MacQueen, S. Campbell, B.S. McEwen, K. Macdonald, S. Amano, and R.T. Joffe Course of illness, hippocampal function, and hippocampal volume in major depression Proc Natl Acad Sci U S A 100 2003 1387 1392
25. B.S. McEwen Stress, sex, and neural adaptation to a changing environment: Mechanisms of neuronal remodeling Ann N Y Acad Sci 1204 2010 E38 E59
26. L. Musazzi, G. Racagni, and M. Popoli Environmental stress, glucocorticoids and glutamate release: Effects of antidepressant drugs Neurochem Int 59 2011 138 149
27. A. Izquierdo, C.L. Wellman, and A. Holmes Brief uncontrollable stress causes dendritic retraction in infralimbic cortex and resistance to fear extinction in mice J Neurosci 26 2006 5733 5738
28. A.M. Magariños, and B.S. McEwen Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: Involvement of glucocorticoid secretion and excitatory amino acid receptors Neuroscience 69 1995 89 98
29. Y. Watanabe, E. Gould, D.C. Daniels, H. Cameron, and B.S. McEwen Tianeptine attenuates stress-induced morphological changes in the hippocampus Eur J Pharmacol 222 1992 157 162
30. J.J. Radley, H.M. Sisti, J. Hao, A.B. Rocher, T. McCall, and P.R. Hof Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex Neuroscience 125 2004 1 6
31. J.J. Cerqueira, R. Taipa, H.B. Uylings, O.F. Almeida, and N. Sousa Specific configuration of dendritic degeneration in pyramidal neurons of the medial prefrontal cortex induced by differing corticosteroid regimens Cereb Cortex 17 2007 1998 2006
32. J.J. Radley, A.B. Rocher, W.G. Janssen, P.R. Hof, B.S. McEwen, and J.H. Morrison Reversibility of apical dendritic retraction in the rat medial prefrontal cortex following repeated stress Exp Neurol 196 2005 199 203
33. G. Rajkowska, J.J. Miguel-Hidalgo, J. Wei, G. Dilley, S.D. Pittman, and H.Y. Meltzer Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression Biol Psychiatry 45 1999 1085 1098
34. R.S. Duman Depression: A case of neuronal life and death? Biol Psychiatry 56 2004 140 145
35. B.N. Cazakoff, and J.G. Howland Acute stress disrupts paired pulse facilitation and long-term potentiation in rat dorsal hippocampus through activation of glucocorticoid receptors Hippocampus 20 2010 1327 1331
36. E.R. Hascup, K.N. Hascup, M. Stephens, F. Pomerleau, P. Huettl, A. Gratton, and G.A. Gerhardt Rapid microelectrode measurements and the origin and regulation of extracellular glutamate in rat prefrontal cortex J Neurochem 115 2010 1608 1620
37. H. Karst, S. Berger, M. Turiault, F. Tronche, G. Schütz, and M. Joëls Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone Proc Natl Acad Sci U S A 102 2005 19204 19207
38. L. Musazzi, M. Milanese, P. Farisello, S. Zappettini, D. Tardito, and V.S. Barbiero Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: The dampening action of antidepressants PLoS One 5 2010 e8566
39. L.R. Reznikov, C.A. Grillo, G.G. Piroli, R.K. Pasumarthi, L.P. Reagan, and J. Fadel Acute stress-mediated increases in extracellular glutamate levels in the rat amygdala: Differential effects of antidepressant treatment Eur J Neurosci 25 2007 3109 3114
40. E. Satoh, and S. Shimeki Acute restraint stress enhances calcium mobilization and glutamate exocytosis in cerebrocortical synaptosomes from mice Neurochem Res 35 2010 693 701
41. F.L. Groeneweg, H. Karst, E.R. de Kloet, and M. Joels Rapid non-genomic effects of corticosteroids and their role in the central stress response J Endocrinol 209 2011 153 167
42. P. Caroni, F. Donato, and D. Muller Structural plasticity upon learning: Regulation and functions Nat Rev Neurosci 13 2012 478 490
43. J.J. Radley, A.B. Rocher, A. Rodriguez, D.B. Ehlenberger, M. Dammann, and B.S. McEwen Repeated stress alters dendritic spine morphology in the rat medial prefrontal cortex J Comp Neurol 507 2008 1141 1150
44. G. Nowak, R. Trullas, R.T. Layer, P. Skolnick, and I.A. Paul Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid J Pharmacol Exp Ther 265 1993 1380 1386
45. P. Skolnick Antidepressants for the new millennium Eur J Pharmacol 375 1999 31 40
46. B. Bobula, K. Tokarski, and G. Hess Repeated administration of antidepressants decreases field potentials in rat frontal cortex Neuroscience 120 2003 765 769
47. K. Tokarski, B. Bobula, J. Wabno, and G. Hess Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex Neuroscience 153 2008 789 795
48. A.T. Michael-Titus, S. Bains, J. Jeetle, and R. Whelpton Imipramine and phenelzine decrease glutamate overow in the prefrontal cortex - a possible mechanism of neuroprotection in major depression? Neuroscience 100 2000 681 684
49. L. Raiteri, M. Raiteri, and G. Bonanno Coexistence and function of different neurotransmitter transporters in the plasma membrane of CNS neurons Prog Neurobiol 68 2002 287 309
50. G. Bonanno, R. Giambelli, L. Raiteri, E. Tiraboschi, S. Zappettini, and L. Musazzi Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus J Neurosci 25 2005 3270 3279
51. V.S. Barbiero, R. Giambelli, L. Musazzi, E. Tiraboschi, D. Tardito, and J. Perez Chronic antidepressants induce redistribution and differential activation of alphaCaM kinase II between presynaptic compartments Neuropsychopharmacology 32 2007 2511 2519
52. E. Celano, E. Tiraboschi, E. Consogno, G. D'Urso, M.P. Mbakop, and M. Gennarelli Selective regulation of presynaptic calcium/calmodulin-dependent protein kinase II by psychotropic drugs Biol Psychiatry 53 2003 442 449
53. G. Racagni, and M. Popoli The pharmacological properties of antidepressants Int Clin Psychopharmacol 25 2010 117 131
54. S.J. Wang, C.F. Su, and Y.H. Kuo Fluoxetine depresses glutamate exocytosis in the rat cerebrocortical nerve terminals (synaptosomes) via inhibition of P/Q-type Ca2+ channels Synapse 48 2003 170 177
55. A. Pittaluga, L. Raiteri, F. Longordo, E. Luccini, V.S. Barbiero, and G. Racagni Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus Neuropharmacology 53 2007 27 36
56. Czéh B, Di Benedetto B (2012): Antidepressants act directly on astrocytes: Evidences and functional consequences [published online ahead of print May 18]. Eur Neuropsychopharmacol.
57. J. Bagley, and B. Moghaddam Temporal dynamics of glutamate efux in the prefrontal cortex and in the hippocampus following repeated stress: Effects of pretreatment with saline or diazepam Neuroscience 77 1997 65 73
58. C. Bonavita, A. Ferrero, M. Cereseto, M. Velardez, M. Rubio, and S. Wikinski Adaptive changes in the rat hippocampal glutamatergic neurotransmission are observed during long-term treatment with lorazepam Psychopharmacology (Berl) 166 2003 163 167
59. L.P. Reagan, L.R. Reznikov, A.N. Evans, C. Gabriel, E. Mocaër, and J.R. Fadel The antidepressant agomelatine inhibits stress-mediated changes in amino acid efflux in the rat hippocampus and amygdala Brain Res 1466 2012 91 98
60. M. Popoli, L. Musazzi, G. Treccani, C. Perego, M. Milanese, and G. Bonanno Behavioural stress and acute corticosterone modify the readily releasable pool of vesicles in glutamatergic terminals of prefrontal and frontal cortex Abstr Soc Neurosci 69 2012 14
61. G.E. Wood, L.T. Young, L.P. Reagan, B. Chen, and B.S. McEwen Stress-induced structural remodeling in hippocampus: Prevention by lithium treatment Proc Natl Acad Sci U S A 101 2004 3973 3978
62. S.D. Norrholm, and C.C. Ouimet Altered dendritic spine density in animal models of depression and in response to antidepressant treatment Synapse 42 2001 151 163
63. T. Hajszan, A. Dow, J.L. Warner-Schmidt, K. Szigeti-Buck, N.L. Sallam, and A. Parducz Remodeling of hippocampal spine synapses in the rat learned helplessness model of depression Biol Psychiatry 65 2009 392 400
64. J.M. Bessa, D. Ferreira, I. Melo, F. Marques, J.J. Cerqueira, and J.A. Palha The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling Mol Psychiatry 14 2009 764 773
65. P. Skolnick, R.T. Layer, P. Popik, G. Nowak, I.A. Paul, and R. Trullas Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: Implications for the pharmacotherapy of depression Pharmacopsychiatry 29 1996 23 26
66. P.A. Boyer, P. Skolnick, and L.H. Fossom Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study J Mol Neurosci 10 1998 219 233
67. B. Ryan, L. Musazzi, A. Mallei, D. Tardito, S.H. Gruber, and A. El Khoury Remodeling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression Int J Neuropsychopharmacol 12 2009 553 559
68. F. Calabrese, G. Guidotti, R. Molteni, G. Racagni, M. Mancini, and M.A. Riva Stress-induced changes of hippocampal NMDA receptors: Modulation by duloxetine treatment PLoS One 7 2012 e37916
69. R. Martínez-Turrillas, J. Del Río, and D. Frechilla Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment Neuropharmacology 49 2005 1178 1188
70. A. Barbon, M. Popoli, L. La Via, S. Moraschi, I. Vallini, and D. Tardito Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs Biol Psychiatry 59 2006 713 720
71. C.H. Tan, X. He, J. Yang, and W.Y. Ong Changes in AMPA subunit expression in the mouse brain after chronic treatment with the antidepressant maprotiline: A link between noradrenergic and glutamatergic function? Exp Brain Res 170 2006 448 456
72. P. Svenningsson, E.T. Tzavara, J.M. Witkin, A.A. Fienberg, G.G. Nomikos, and P. Greengard Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac) Proc Natl Acad Sci U S A 99 2002 3182 3187
73. J. Du, N.A. Gray, C.A. Falke, W. Chen, P. Yuan, and S.T. Szabo Modulation of synaptic plasticity by antimanic agents: The role of AMPA glutamate receptor subunit 1 synaptic expression J Neurosci 24 2004 6578 6589
74. Zhang J, Narr KL, Woods RP, Phillips OR, Alger JR, Espinoza RT (2012): Glutamate normalization with ECT treatment response in major depression [published online ahead of print May 8]. Mol Psychiatry.
75. A. Pilc, S. Chaki, G. Nowak, and J.M. Witkin Mood disorders: Regulation by metabotropic glutamate receptors Biochem Pharmacol 75 2008 997 1006
76. D.D. Schoepp Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system J Pharmacol Exp Ther 299 2001 12 20
77. M. Smiałowska, B. Szewczyk, P. Branski, J.M. Wieronska, A. Pałucha, M. Bajkowska, and A. Pilc Effect of chronic imipramine or electroconvulsive shock on the expression of mGluR1a and mGluR5a immunoreactivity in rat brain hippocampus Neuropharmacology 42 2002 1016 1023
78. F. Matrisciano, M. Storto, R.T. Ngomba, I. Cappuccio, A. Caricasole, and S. Scaccianoce Imipramine treatment up-regulates the expression and function of mGlu2/3 metabotropic glutamate receptors in the rat hippocampus Neuropharmacology 42 2002 1008 1015
79. J.M. Wieronska, K. Kłak, A. Pałucha, P. Branski, and A. Pilc Citalopram influences mGlu7, but not mGlu4 receptors' expression in the rat brain hippocampus and cortex Brain Res 1184 2007 88 95
80. O'Connor RM, Pusceddu MM, Dinan TG, Cryan JF (2012): Impact of early-life stress, on group III mGlu receptor levels in the rat hippocampus: Effects of ketamine, electroconvulsive shock therapy and fluoxetine treatment [published online ahead of print May 17]. Neuropharmacology.
81. R.M. Berman, A. Cappiello, A. Anand, D.A. Oren, G.R. Heninger, D.S. Charney, and J.H. Krystal Antidepressant effects of ketamine in depressed patients Biol Psychiatry 47 2000 351 354
82. L. Ibrahim, N. Diazgranados, J. Franco-Chaves, N. Brutsche, I.D. Henter, and P. Kronstein Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: Results from a 4-week, double-blind, placebo-controlled study Neuropsychopharmacology 37 2012 1526 1533
83. M. Aan Het Rot, C.A. Zarate Jr, D.S. Charney, and S.J. Mathew Ketamine for depression: Where do we go from here? Biol Psychiatry 72 2012 537 547
84. N. Li, B. Lee, R.J. Liu, M. Banasr, J.M. Dwyer, and M. Iwata mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists Science 329 2010 959 964
85. N. Li, R.J. Liu, J.M. Dwyer, M. Banasr, B. Lee, H. Son, and X.Y. Li Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure Biol Psychiatry 69 2011 754 761
86. P. Popik, T. Kos, M. Sowa-Kućma, and G. Nowak Lack of persistent effects of ketamine in rodent models of depression Psychopharmacology (Berl) 198 2008 421 430
87. S. Maeng, C.A. Zarate Jr, J. Du, R.J. Schloesser, J. McCammon, G. Chen, and H.K. Manji Cellular mechanisms underlying the antidepressant effects of ketamine: Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors Biol Psychiatry 63 2008 349 352
88. M. Dybała, A. Siwek, E. Poleszak, A. Pilc, and G. Nowak Lack of NMDA-AMPA interaction in antidepressant-like effect of CGP 37849, an antagonist of NMDA receptor, in the forced swim test J Neural Transm 115 2008 1519 1520
89. J. Du, R. Machado-Vieira, S. Maeng, K. Martinowich, H.K. Manji, and C.A. Zarate Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action Drug Discovery Today Ther Strateg 3 2006 519 526
90. M.J. O'Neill, D. Bleakman, D.M. Zimmerman, and E.S. Nisenbaum AMPA receptor potentiators for the treatment of CNS disorders Curr Drug Targets CNS Neurol Disord 3 2004 181 194
91. X. Li, J.P. Tizzano, K. Griffey, M. Clay, T. Lindstrom, and P. Skolnick Anti depressant-like actions of an AMPA receptor potentiator (LY392098) Neuropharmacology 40 2001 1028 1033
92. Chaki S, Ago Y, Palucha-Paniewiera A, Matrisciano F, Pilc A (2012): mGlu2/3 and mGlu5 receptors: Potential targets for novel antidepressants [published online ahead of print May 26]. Neuropharmacology.
93. R.M. O'Connor, B.C. Finger, P.J. Flor, and J.F. Cryan Metabotropic glutamate receptor 7: At the interface of cognition and emotion Eur J Pharmacol 639 2010 123 131
94. H. Koike, M. Iijima, and S. Chaki Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists Neuropharmacology 61 2011 1419 1423
95. J.M. Dwyer, A.E. Lepack, and R.S. Duman mTOR activation is required for the antidepressant effects of mGluR2/3 blockade Int J Neuropsychopharmacol 15 2012 429 434
96. C. Liston, M.M. Miller, D.S. Goldwater, J.J. Radley, A.B. Rocher, and P.R. Hof Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting J Neurosci 26 2006 7870 7874
97. R.S. Duman, and L.M. Monteggia A neurotrophic model for stress-related mood disorders Biol Psychiatry 59 2006 1116 1127
98. A.E. Autry, M. Adachi, E. Nosyreva, E.S. Na, M.F. Los, and P.F. Cheng NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses Nature 475 2011 91 95
99. G. Baj, V. D'Alessandro, L. Musazzi, A. Mallei, C.R. Sartori, and M. Sciancalepore Physical exercise and antidepressants enhance BDNF targeting in hippocampal CA3 dendrites: Further evidence of a spatial code for BDNF splice variants Neuropsychopharmacology 37 2012 1600 1611
100. A. Mallei, G. Baj, S. Corna, D. Tardito, F. Lee, and E. Tongiorgi Analysis of epigenetic changes reveals selective impairment of BDNF-6 expression and dendritic translocation in transgenic mice carrying the BDNF Val66Met human polymorphism Abstr Soc Neurosci 167 2012 06
101. I.A. Paul, G. Nowak, R.T. Layer, P. Popik, and P. Skolnick Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments J Pharmacol Exp Ther 269 1994 95 102
102. G. Nowak, B. Legutko, P. Skolnick, and P. Popik Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors Eur J Pharmacol 342 1998 367 370
103. E. Ampuero, F.J. Rubio, R. Falcon, M. Sandoval, G. Diaz-Veliz, and RE Gonzalez Chronic fluoxetine treatment induces structural plasticity and selective changes in glutamate receptor subunits in the rat cerebral cortex Neuroscience 169 2010 98 108
104. R. Martinez-Turrillas, D. Frechilla, and J. Del Río Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus Neuropharmacology 43 2002 1230 1237
105. R. Martínez-Turrillas, J. Del Río, and D. Frechilla Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment Neuropharmacology 49 2005 1178 1188
106. V. Szegedi, G. Juhász, X. Zhang, B. Barkóczi, H. Qi, and A Madeira Tianeptine potentiates AMPA receptors by activating CaMKII and PKA via the p38, p42/44 MAPK and JNK pathways Neurochem Int 59 2011 1109 1122